Know and Own Your Movement-related Metrics Via Wearable Devices

Completed · Not applicable

Conditions studied: Cancer, Survivorship

In brief

This study aims to promote daily physical activity in cancer survivors who are at high risk for type 2 diabetes (T2D) by using a personalized biological-based feedback strategy. T2D is one of the most common co-occurring conditions in cancer survivors and can worsen cancer-related health outcomes, especially in those who are insufficiently active. The investigators hypothesize that seeing the immediate impacts of exercise on their biological status will motivate cancer survivors to exercise. The investigators will use real-time data from continuous glucose monitor to demonstrate the acute impact of physical activity and measure daily activity levels using wearable trackers. As wearable sensor technology is constantly advancing, this study is the first step to exploring how researchers can use wearable sensors to help people make a direct connection between their daily behaviors and health outcomes.

Key facts

Study ID

NCT05490641

Run by

The University of Texas at Arlington

People needed

60

Starts

2023-03-29

Expected to finish

2025-12-10

Last updated by the study team

2026-02-13

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• be 18 years or older
• have had a diagnosis of cancer
• have completed curative-intended treatment for at least 3 months (except hormone therapy or long-term maintenance chemotherapy)
• be at high-risk for type 2 diabetes based on the American Diabetes Association Type 2 Diabetes Risk Test
• currently insufficiently active
• capable of participating in moderate-vigorous intensity unsupervised exercise
• have no current diagnosis or history of type 1 or 2 diabetes
• able to speak, read, and write in English
• have a smartphone with daily internet access

You may not qualify if…

• currently taking oral antidiabetic agents (OADs)
• current treatment with any insulin regimen other than basal insulin, e.g. prandial or pre-mixed insulin
• currently pregnant
• on dialysis
• have self-reported health issues that limit physical activity
• work overnight shifts
• unwilling to use the study devices
• current participation in other exercise or weight loss-related program or intervention
• currently on a low-carb diet
• current use of other implanted medical devices such as pacemakers
• do not have a smartphone that is compatible with the Fitbit and the LibreLink apps

Where it is running

• The University of Texas at Arlington — Arlington, Texas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.